Skip to main content

Paper-Based Test Scans for Multiple Biomarkers in Human Serum

 









Researchers led by UCLA professor Aydogan Ozcan developed a deep learning-enabled biosensor for multiplexed, point-of-care (POC) testing of disease biomarkers. POC biosensors provide remote and resource-limited communities with an economical, practical alternative to centralized laboratory testing.
The UCLA-developed POC sensor includes a paper-based fluorescence vertical flow assay to simultaneously detect three biomarkers of acute coronary syndrome from human serum samples. The vertical flow assay is processed by a low-cost mobile reader, which quantifies the target biomarkers through trained neural networks.

According to the researchers, the competitive performance of the multiplexed computational fluorescence vertical flow assay, along with its inexpensive, paper-based design and hand-held footprint, give the POC sensor promise as a platform to expand access to diagnostics in resource-limited settings.

“Compared to a commonly used linear calibration method, our deep learning-based analysis benefits from the function approximation power of neural networks to learn nontrivial relationships between the multiplexed fluorescence signals from the paper-based sensor and the underlying analyte concentrations in serum,” researcher Artem Goncharov said. “As a result, we have accurate quantitative measurements for all three biomarkers of interest, despite the background noise present in clinical serum samples.”

Unlike lateral flow assays, which are the most common type of POC test, assays using the vertical flow of samples through stacked paper layers enable the arrangement of sensing regions in a 2D or 3D array and can achieve multiplexing with tens or even hundreds of independent testing channels represented by different affinity capture molecules. The vertical flow design of the POC sensor from the UCLA researchers has room for multiple test regions, with up to 100 individual test spots within a single disposable cartridge.

“This design essentially allows us to integrate tens of different POC sensors into a single cassette and perform multiplexed diagnostics tests in parallel with the same low-cost paper-based sensor,” Ozcan said.

The researchers used conjugated polymer nanoparticles (CPNs) — fluorescent labels with tunable emission and excitation properties and with minimally overlapping excitation and emission peaks — to design the fluorescence vertical flow assay. The CPNs have 480-nm excitation and 610-nm emission peaks, which helped the team reduce the strong autofluorescence background from the paper substrate.

The excitation energy transfer in CPNs takes place across the whole backbone, catalyzing an amplified emission that is higher than quantum dots (QDs). CPNs are also more stable on porous paper layers, with less photobleaching, and are larger than QDs, leading to improved luminescence.

Using human serum samples to quantify three cardiac biomarkers — myoglobin, creatine kinase-MB, and heart-type fatty acid binding protein — the researchers validated the fluorescence vertical flow assay platform. The assay achieved less than 0.52 ng/mL−1 limit-of-detection for all three biomarkers, with minimal cross-reactivity.

Biomarker concentration quantification, using the assay coupled to neural network-based inference, was blindly tested using 46 individually activated cartridges and human serum samples. The results showed a high correlation between the fluorescence vertical flow assay and the ground truth concentrations obtained through standard laboratory benchtop testing, with a greater than 0.9 linearity and a less than 15% coefficient of variation found for all three biomarkers.

The simple-to-operate POC sensor, the researchers said, involves only three injection steps performed through a single loading inlet. The steps can be executed by a minimally trained technician using a custom operation kit. The assay uses 50 µL of serum sample per patient and takes under 15 minutes to complete, which is on the same scale as, for example, COVID-19 rapid antigen tests that take between 15 and 30 minutes.

Bio Photonics Research Award

Visit: biophotonicsresearch.com
Nominate Now: https://biophotonicsresearch.com/award-nomination/?ecategory=Awards&rcategory=Awardee

#MeatAnalysis #FluorescenceTech #FoodQuality #FoodSafety #SpectroscopyInFood #MeatAuthentication #RapidDetection #FoodScience #MeatFreshness #MolecularDetection #FoodIndustryInnovation #NonDestructiveTesting #FoodMonitoring #SpectroscopyApplications #QualityControl #AdvancedSpectroscopy #MeatSpoilageDetection #FoodIntegrity #SmartFoodTesting #RealTimeAnalysis #FoodAuthenticity #FoodSafetyInnovation #SpectroscopyResearch #NextGenFoodSafety #InnovativeFoodScience,

Comments

Popular posts from this blog

Abrisa Technologies Acquires Agama Glass Technologies

SANTA PAULA, Calif. — Abrisa Technologies, a provider of custom glass optics and thin film coatings and a subsidiary of HEF Photonics, has acquired Agama Glass Technologies, a manufacturer of etched anti-glare glass and technical glass processing. The acquisition, Abrisa said, expands its manufacturing footprint and adds a vertically integrated solution for chemically etched anti-glare display glass. According to Abrisa, Clarksburg, West Virginia-based Agama operates North America’s only high-volume technical glass etching facility. Agama's flagship product, AgamaEtch, is used in high-performance display and optics applications. The company's 85,000 sq ft facility also offers precision glass fabrication, chemical strengthening, and silk-screen printing, serving markets such as avionics, defense, medical, industrial, and touchscreen displays. Combined with Abrisa Technologies’ and HEF Photonics’ thin-film coating and surface engineering capabilities, Agama's offerings wi...

How Biophotonics Is Harnessing Light for Health And Science

Fifty or so years ago French physicist Pierre Aigrain coined the term photonics as a research field whose goal was to use light to perform functions that traditionally fell within the typical domain of electronics, such as telecommunications, and information processing. Or maybe it was John Campbell who, in a letter sent to Gotthard Gunther in 1954, wrote, “Incidentally, I’ve decided to invent a new science — photonics. It bears the same relationship to Optics that electronics does to electrical engineering. Photonics, like electronics, will deal with the individual units; optics and EE deal with the group phenomena! And note that you can do things with electronics that are impossible in electrical engineering!” Naming rights aside, the field of photonics began in earnest between 1958 and 1960 with the invention of the maser and the laser. The laser diode followed during the 1970s, optical fibers and the erbium-doped fiber amplifier after that, and, pretty soon, the telecommunications...

Laser Method Enables Fast & Precise Blood Vessels in Hydrogel

Researchers from Vienna University of Technology (TU Wien) and Keio University have found a way to create artificial blood vessels in miniature organ models in a quick and reproducible manner. The method utilizes ultrashort laser pulses in the femtosecond range to write highly 3D structures into a hydrogel. In biomedical research, organs-on-a-chip are becoming increasingly important: By cultivating tissue structures in precisely controlled microfluidic chips, it is possible to conduct research much more accurately than in experiments involving living humans or animals. However, there has been a major obstacle: such mini-organs are incomplete without blood vessels. To facilitate systematic studies and ensure meaningful comparisons with living organisms, a network of perfusable blood vessels and capillaries must be created — in a way that is precisely controllable and reproducible. “We can create channels spaced only a hundred micrometers apart. That’s essential when you would like to...